CYTK:NASDAQ
Cytokinetics, Inc.
65,91 USD
arrow_upward
+0,41%(+0,27) 1D
65,00 USD
arrow_downward
−1,38% (−0,91)bedtimeNakon radnog vremena
Zatvoreno: 30. ruj, 16:00:01 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za CYTK...
Otvori
65,90 USD
Najviša
66,92 USD
Najniža
65,25 USD
Trž. kap.
9,16 mlr.
Prosj. kol.
1,95 mil.
Količina
27,00
52-tjed. najviša
88,31 USD
52-tjed. najniža
53,61 USD
EPS
−7,22 USD
Beta
0,36
Dionice u optjecaju
139,02 mil.
Broj djelatnika
673
Otvori
65,90 USD
Najviša
66,92 USD
Najniža
65,25 USD
Trž. kap.
9,16 mlr.
Prosj. kol.
1,95 mil.
Količina
27,00
52-tjed. najviša
88,31 USD
52-tjed. najniža
53,61 USD
EPS
−7,22 USD
Beta
0,36
Dionice u optjecaju
139,02 mil.
Broj djelatnika
673
Vijesti
Iz web-izvora i od partnera za vijesti
Simply Wall Street
·
prije 12 sati
Is Real World Study Launch Altering The Investment Case For Cytokinetics (CYTK)?
GuruFocus
·
prije 22 sata
Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo in Obstructive Hypertrophic Cardiomyopathy
Stock Titan
·
prije 23 sata
A new study aims to enroll about 400 adults to assess a heart drug in everyday care.
Investing.com Canada
·
prije 2 dana
Form 4 Cytokinetics Inc For: 29 September By Investing.com
Profil
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
Cytokinetics, Inc. – informacije
Glavni izvršni direktorRobert I. Blum | Robert I. Blum
Zaposlenici673
Osnovano1997
SjedišteSouth San Francisco, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijacytokinetics.com